Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bausch Health Companies Inc., formerly known as Valeant Pharmaceuticals, is a global diversified pharmaceutical company headquartered in Laval, Quebec. The company develops, manufactures, and markets a broad range of products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The name "Valiant Pharmacy" is likely a reference to Valeant Pharmaceuticals, which underwent a high-profile rebranding in 2018 following significant scrutiny regarding its business model and its historical relationship with specialty pharmacies like Philidor Rx Services. Today, Bausch Health operates through major business units including Bausch + Lomb, Salix Pharmaceuticals, and Ortho Dermatologics. The company maintains an extensive portfolio of established brands such as Xifaxan and Lumify, while advancing a clinical pipeline focused on line extensions and new therapeutic entities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Valiant Pharmacy.